News in brief: ECS explores US move; Epsilon reports half-year results by Steve Jones December 16, 2025December 22, 2025 ECS Botanics is exploring ways it could enter the US medicinal cannabis market amid reports President […]
Epsilon working with ASX as two-year suspension deadline approaches by Adam Sheldon December 9, 2025December 10, 2025
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025December 4, 2025
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025September 17, 2025
News in brief: Shahin becomes Vitura’s largest shareholder; Avecho progresses CBD insomnia trial; Epsilon reports improved cashflow; Zelira locks in R&D loan to advance trial by Adam Sheldon July 31, 2025July 31, 2025
Epsilon announces new company secretary, eyes lifting of ASX trading suspension by Martin Lane August 20, 2024January 13, 2025
‘Back on track’: Epsilon plots growth after seven-month saga but storm clouds remain by Steve Jones August 7, 2024August 8, 2024
‘Significant’ probe underway as Epsilon creditors raise ‘various matters’ by Steve Jones January 31, 2024July 11, 2024
